Eikon Therapeutics targets $908.2 million valuation in U.S. IPO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. AWK
8. DRI
9. ULS
10. VEON

Go back to Eikon Therapeutics targets $908.2 million valuation in U.S. IPO
(NASDAQ: EIKN) Delayed: 7.92 -0.37 (4.46%)
Previous Close $8.29    52 Week High $ 
Open $8.45    52 Week Low $ 
Day High $8.47    P/E N/A 
Day Low $7.87    EPS $ 
Volume 377,186